
Mangoceuticals Subsidiary Secured $2.5 Million Funding
Dallas-based Mangoceuticals raised capital for its IP subsidiary by selling membership interests instead of stock.
Live Poll
Do you trust that subsidiary-level deals protect public shareholders from stock dilution?